2021 Q4 Form 10-Q Financial Statement

#000121390022006429 Filed on February 10, 2022

View on sec.gov

Income Statement

Concept 2021 Q4
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.801M
YoY Change 92.96%
% of Gross Profit
Research & Development $5.458M
YoY Change -11.83%
% of Gross Profit
Depreciation & Amortization $730.00
YoY Change
% of Gross Profit
Operating Expenses $9.259M
YoY Change 13.47%
Operating Profit -$9.259M
YoY Change
Interest Expense $33.98K
YoY Change 239.8%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$9.225M
YoY Change 13.19%
Income Tax
% Of Pretax Income
Net Earnings -$9.225M
YoY Change 13.24%
Net Earnings / Revenue
Basic Earnings Per Share -$0.06
Diluted Earnings Per Share -$63.18K
COMMON SHARES
Basic Shares Outstanding 146.0M shares
Diluted Shares Outstanding 146.0M shares

Balance Sheet

Concept 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $65.42M
YoY Change 1421.43%
Cash & Equivalents $65.42M
Short-Term Investments
Other Short-Term Assets $2.524M
YoY Change 94.12%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $67.94M
YoY Change 1113.3%
LONG-TERM ASSETS
Property, Plant & Equipment $786.2K
YoY Change -12.64%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $38.06K
YoY Change
Total Long-Term Assets $69.57M
YoY Change 134.25%
TOTAL ASSETS
Total Short-Term Assets $67.94M
Total Long-Term Assets $69.57M
Total Assets $137.5M
YoY Change 289.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.789M
YoY Change 78.92%
Accrued Expenses $5.552M
YoY Change 131.35%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.342M
YoY Change 109.76%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change -100.0%
Other Long-Term Liabilities $630.8K
YoY Change -21.16%
Total Long-Term Liabilities $630.8K
YoY Change -36.93%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.342M
Total Long-Term Liabilities $630.8K
Total Liabilities $13.56M
YoY Change 34.24%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $124.0M
YoY Change
Total Liabilities & Shareholders Equity $137.5M
YoY Change 289.56%

Cashflow Statement

Concept 2021 Q4
OPERATING ACTIVITIES
Net Income -$9.225M
YoY Change 13.24%
Depreciation, Depletion And Amortization $730.00
YoY Change
Cash From Operating Activities -$4.652M
YoY Change -51.34%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities -4.652M
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash $0.00
YoY Change -100.0%
FREE CASH FLOW
Cash From Operating Activities -$4.652M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 dei Entity Central Index Key
EntityCentralIndexKey
0001506251
CY2020Q4 ctxr Issuance Of Common Stock For Services
IssuanceOfCommonStockForServices
USD
CY2021Q4 ctxr Increase Decrease In Other Deposit
IncreaseDecreaseInOtherDeposit
USD
CY2021Q4 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
USD
CY2021Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
USD
CY2021Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
USD
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2021Q4 us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
shares
CY2020Q4 us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
shares

Files In Submission

Name View Source Status
0001213900-22-006429-index-headers.html Edgar Link pending
0001213900-22-006429-index.html Edgar Link pending
0001213900-22-006429.txt Edgar Link pending
0001213900-22-006429-xbrl.zip Edgar Link pending
ctxr-20211231.xsd Edgar Link pending
ctxr-20211231_cal.xml Edgar Link unprocessable
ctxr-20211231_def.xml Edgar Link unprocessable
ctxr-20211231_lab.xml Edgar Link unprocessable
ctxr-20211231_pre.xml Edgar Link unprocessable
f10q1221ex31-1_citiuspharma.htm Edgar Link pending
f10q1221ex31-2_citiuspharma.htm Edgar Link pending
f10q1221ex32-1_citiuspharma.htm Edgar Link pending
f10q1221_citiuspharma.htm Edgar Link pending
f10q1221_citiuspharma_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending